Free Trial!
Today’s Best Stocks To Trade! Click Here
OSI Pharmaceuticals (OSIP | Quote | Chart | News | PowerRating) said the FDA has accepted a New Drug application for Tarceva plus gemcitabine chemotherapy for pancreatic cancer treatment. In additions, Tarceva was granted priority review classification.
Zion's Bancorp will acquire Amegy for $1.7 billion.
UBS raised June estimates on Intel (INTC | Quote | Chart | News | PowerRating), to 0.33 from 0.32.
JP Morgan raised estimates on Motorola (MOT | Quote | Chart | News | PowerRating).
Marvel Enterprises (MVL | Quote | Chart | News | PowerRating) was downgraded to neutral at JP Morgan.
Zoll Medical (ZOLL | Quote | Chart | News | PowerRating) warned for Q3; the company now expects breakeven vs 0.10.
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
